Cargando…
High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616883/ https://www.ncbi.nlm.nih.gov/pubmed/36307399 http://dx.doi.org/10.1038/s41408-022-00740-3 |
| _version_ | 1784820736756547584 |
|---|---|
| author | Li, Jun Han, Qi Huang, Yanqing Wei, Yanhui Zi, Jie Zhao, Lidong Cai, Zhimei Lu, Xuzhang Xiao, Rong Zhang, Yanming Yang, Xiaotian Xu, Hao Sun, Naitong Zhuang, Wanchuan Wu, Zhengdong Xia, Yuan Xu, Yanli He, Bin Zhu, Wei Min, Fengling Chen, Yongchun Ding, Banghe Shi, Peimin Xie, Jing Tang, Hua Liu, Zefa Li, Bingzong Sun, Yu Qiu, Hongxia Duan, Limin Dovat, Elanora Song, Chunhua SzeKely, Laszlo Dovat, Sinisa Ge, Zheng |
| author_facet | Li, Jun Han, Qi Huang, Yanqing Wei, Yanhui Zi, Jie Zhao, Lidong Cai, Zhimei Lu, Xuzhang Xiao, Rong Zhang, Yanming Yang, Xiaotian Xu, Hao Sun, Naitong Zhuang, Wanchuan Wu, Zhengdong Xia, Yuan Xu, Yanli He, Bin Zhu, Wei Min, Fengling Chen, Yongchun Ding, Banghe Shi, Peimin Xie, Jing Tang, Hua Liu, Zefa Li, Bingzong Sun, Yu Qiu, Hongxia Duan, Limin Dovat, Elanora Song, Chunhua SzeKely, Laszlo Dovat, Sinisa Ge, Zheng |
| author_sort | Li, Jun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9616883 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96168832022-10-30 High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study Li, Jun Han, Qi Huang, Yanqing Wei, Yanhui Zi, Jie Zhao, Lidong Cai, Zhimei Lu, Xuzhang Xiao, Rong Zhang, Yanming Yang, Xiaotian Xu, Hao Sun, Naitong Zhuang, Wanchuan Wu, Zhengdong Xia, Yuan Xu, Yanli He, Bin Zhu, Wei Min, Fengling Chen, Yongchun Ding, Banghe Shi, Peimin Xie, Jing Tang, Hua Liu, Zefa Li, Bingzong Sun, Yu Qiu, Hongxia Duan, Limin Dovat, Elanora Song, Chunhua SzeKely, Laszlo Dovat, Sinisa Ge, Zheng Blood Cancer J Correspondence Nature Publishing Group UK 2022-10-28 /pmc/articles/PMC9616883/ /pubmed/36307399 http://dx.doi.org/10.1038/s41408-022-00740-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Li, Jun Han, Qi Huang, Yanqing Wei, Yanhui Zi, Jie Zhao, Lidong Cai, Zhimei Lu, Xuzhang Xiao, Rong Zhang, Yanming Yang, Xiaotian Xu, Hao Sun, Naitong Zhuang, Wanchuan Wu, Zhengdong Xia, Yuan Xu, Yanli He, Bin Zhu, Wei Min, Fengling Chen, Yongchun Ding, Banghe Shi, Peimin Xie, Jing Tang, Hua Liu, Zefa Li, Bingzong Sun, Yu Qiu, Hongxia Duan, Limin Dovat, Elanora Song, Chunhua SzeKely, Laszlo Dovat, Sinisa Ge, Zheng High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| title | High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| title_full | High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| title_fullStr | High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| title_full_unstemmed | High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| title_short | High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| title_sort | high efficacy of azacitidine plus hag in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616883/ https://www.ncbi.nlm.nih.gov/pubmed/36307399 http://dx.doi.org/10.1038/s41408-022-00740-3 |
| work_keys_str_mv | AT lijun highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT hanqi highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT huangyanqing highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT weiyanhui highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT zijie highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT zhaolidong highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT caizhimei highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT luxuzhang highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT xiaorong highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT zhangyanming highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT yangxiaotian highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT xuhao highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT sunnaitong highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT zhuangwanchuan highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT wuzhengdong highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT xiayuan highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT xuyanli highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT hebin highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT zhuwei highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT minfengling highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT chenyongchun highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT dingbanghe highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT shipeimin highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT xiejing highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT tanghua highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT liuzefa highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT libingzong highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT sunyu highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT qiuhongxia highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT duanlimin highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT dovatelanora highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT songchunhua highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT szekelylaszlo highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT dovatsinisa highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study AT gezheng highefficacyofazacitidineplushaginacutemyeloidleukemiaanopenlabelsinglearmmulticenterphase2study |